Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#131 / 200 Total
GENK - GEN Restaurant Group Inc - Stock Price Chart
TickerGENK [NASD]
CompanyGEN Restaurant Group Inc
CountryUSA
IndustryRestaurants
Market Cap44.07MEPS (ttm)0.26
P/E38.70EPS this Y-8.33%
Forward P/E51.57EPS next Y163.64%
PEG-EPS past 5Y-
P/S0.24EPS next 5Y-
P/B4.60EPS Q/Q12.12%
Dividend-Sales Q/Q10.43%
Insider Own6.31%Inst Own74.36%
Insider Trans185.08%Inst Trans-
Short Float3.87%EarningsMar 06/a
Analyst Recom1.00Target Price11.33
Avg Volume91.62K52W Range5.61 - 20.50
GEN Restaurant Group, Inc. engages in the operation of casual dining restaurants. It offers traditional Korean and Korean-American food, including meats, poultry, and seafood. The company was founded by Jae Chang and David Kim in September 2011 and is headquartered in Cerritos, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kim David Wook JinCo-Chief Executive OfficerMar 15 '24Buy8.056,00048,280130,093Mar 19 06:00 PM
Wang Lauren10% OwnerMar 15 '24Buy8.056,00048,280130,093Mar 19 06:00 PM
Kim Don10% OwnerMar 15 '24Buy8.056,00048,280130,093Mar 19 06:00 PM
Manzanarez Jose10% OwnerMar 15 '24Buy8.056,00048,280130,093Mar 19 06:00 PM
Wang Lauren10% OwnerMar 14 '24Buy7.437,00052,000124,093Mar 15 06:00 PM
CCEL - Cryo-Cell International, Inc. - Stock Price Chart
TickerCCEL [AMEX]
CompanyCryo-Cell International, Inc.
CountryUSA
IndustryMedical Care Facilities
Market Cap68.44MEPS (ttm)-1.18
P/E-EPS this Y107.89%
Forward P/E52.81EPS next Y77.78%
PEG-EPS past 5Y-58.40%
P/S2.18EPS next 5Y-
P/B-EPS Q/Q-26.19%
Dividend-Sales Q/Q0.36%
Insider Own51.12%Inst Own5.75%
Insider Trans0.00%Inst Trans-8.15%
Short Float0.43%EarningsApr 15/a
Analyst Recom1.00Target Price9.00
Avg Volume10.91K52W Range3.67 - 8.15
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage, and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded in 1989 and is headquartered in Oldsmar, FL.
MAMA - Mama's Creations Inc. - Stock Price Chart
TickerMAMA [NASD]
CompanyMama's Creations Inc.
CountryUSA
IndustryPackaged Foods
Market Cap223.56MEPS (ttm)0.18
P/E34.23EPS this Y-4.41%
Forward P/E25.81EPS next Y43.08%
PEG-EPS past 5Y65.18%
P/S2.16EPS next 5Y-
P/B11.35EPS Q/Q-23.39%
Dividend-Sales Q/Q17.13%
Insider Own10.76%Inst Own47.91%
Insider Trans-58.41%Inst Trans-0.91%
Short Float1.68%EarningsApr 24/a
Analyst Recom1.00Target Price7.88
Avg Volume261.22K52W Range1.83 - 5.79
Mama's Creations, Inc. engages in the marketing, manufacturing, and distribution of beef meatballs with sauce, turkey meatballs with sauce, beef meat loaf, sausage and peppers, chicken parmesan, and other similar meats and sauces. Its products include beef meatballs, turkey meatballs, stuffed meatballs, lasagna roll ups, retail ready meals, bulk deli, single-size pasta bowls, and packaged refrigerated products. Its brands include MamaMancini's, Creative Salads, and The Olive Branch. The company was founded by Daniel Dougherty on July 22, 2009 and is headquartered in East Rutherford, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brown Matthew10% OwnerDec 21 '23Sale3.505,629,92119,704,7240Dec 21 04:30 PM
Janeway DeanDirectorAug 21 '23Option Exercise0.8025,00020,000218,461Aug 22 09:41 PM
Burns Steven R.DirectorAug 21 '23Option Exercise0.8025,00020,00077,972Aug 23 04:05 PM
Toto Thomas G.DirectorAug 21 '23Option Exercise0.8025,00020,000654,443Aug 22 09:41 PM
D'Agostino AlfredDirectorAug 18 '23Option Exercise0.8025,00020,00069,348Aug 22 09:41 PM
STTK - Shattuck Labs Inc - Stock Price Chart
TickerSTTK [NASD]
CompanyShattuck Labs Inc
CountryUSA
IndustryBiotechnology
Market Cap503.55MEPS (ttm)-2.05
P/E-EPS this Y15.79%
Forward P/E-EPS next Y-2.36%
PEG-EPS past 5Y-63.20%
P/S303.35EPS next 5Y-
P/B3.46EPS Q/Q31.40%
Dividend-Sales Q/Q83.08%
Insider Own14.17%Inst Own58.70%
Insider Trans-0.60%Inst Trans-3.74%
Short Float4.40%EarningsFeb 29/a
Analyst Recom1.00Target Price15.75
Avg Volume325.96K52W Range1.33 - 11.11
Apr-09-24 04:05PM Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024 (GlobeNewswire)
Apr-01-24 07:00AM Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-04-24 07:00AM Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors (GlobeNewswire)
Feb-29-24 04:05PM Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights (GlobeNewswire)
Feb-26-24 07:00AM Shattuck Labs Announces Participation in Upcoming March Conferences (GlobeNewswire)
Feb-14-24 05:06AM Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins (PR Newswire) +6.03%
Feb-13-24 06:00AM Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases (GlobeNewswire) -5.37%
Jan-08-24 07:00AM Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024 (GlobeNewswire) +14.94%
Jan-04-24 04:05PM Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-21-23 08:00AM Shattuck Labs Announces $50 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants (GlobeNewswire)
Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stout StephenSee RemarksMar 06 '24Option Exercise3.5411,10939,38085,791Mar 08 05:40 PM
Stout StephenSee RemarksMar 06 '24Sale10.5316,004168,52274,437Mar 08 05:40 PM
Neill Andrew RChief Financial OfficerJan 10 '24Sale10.0025,000250,000173,446Jan 16 04:35 PM
JAN - JanOne Inc - Stock Price Chart
TickerJAN [NASD]
CompanyJanOne Inc
CountryUSA
IndustryBiotechnology
Market Cap43.81MEPS (ttm)-4.67
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y23.21%
P/S-EPS next 5Y-
P/B-EPS Q/Q-9.46%
Dividend-Sales Q/Q-100.00%
Insider Own11.05%Inst Own3.61%
Insider Trans0.00%Inst Trans-7.88%
Short Float1.93%Earnings-
Analyst Recom-Target Price-
Avg Volume315.22K52W Range0.22 - 5.08
JanOne, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.
YSG - Yatsen Holding Ltd ADR - Stock Price Chart
TickerYSG [NYSE]
CompanyYatsen Holding Ltd ADR
CountryChina
IndustryHousehold & Personal Products
Market Cap360.00MEPS (ttm)-0.90
P/E-EPS this Y195.38%
Forward P/E12.23EPS next Y76.84%
PEG-EPS past 5Y-78.64%
P/S0.75EPS next 5Y-
P/B0.89EPS Q/Q-4758.78%
Dividend0.64%Sales Q/Q5.03%
Insider Own8.99%Inst Own15.14%
Insider Trans0.00%Inst Trans-18.27%
Short Float0.98%EarningsMar 06/b
Analyst Recom2.33Target Price4.38
Avg Volume406.89K52W Range1.99 - 6.65
Yatsen Holding Ltd. engages in selling beauty products. It operates through the following segments: Color Cosmetics Brands, Skincare Brands, and Others. The company was founded by Jin Feng Huang, Yu Wen Chen, and Jian Hua Lyu on September 12, 2016 and is headquartered in Guangzhou, China.
PASG - Passage Bio Inc - Stock Price Chart
TickerPASG [NASD]
CompanyPassage Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap81.33MEPS (ttm)-1.86
P/E-EPS this Y36.02%
Forward P/E-EPS next Y18.04%
PEG-EPS past 5Y-46.23%
P/S-EPS next 5Y-
P/B0.65EPS Q/Q38.47%
Dividend-Sales Q/Q-
Insider Own33.07%Inst Own25.82%
Insider Trans-0.17%Inst Trans-5.98%
Short Float4.25%EarningsMar 04/b
Analyst Recom1.00Target Price7.00
Avg Volume348.69K52W Range0.58 - 1.79
Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Forman Mark SCHIEF MEDICAL OFFICERFeb 13 '24Sale0.971,6381,58948,631Feb 13 07:34 PM
Borthwick KathleenSVP, INTERIM CFOFeb 13 '24Sale0.971,4701,42628,466Feb 13 07:36 PM
Forman Mark SChief Medical OfficerJan 02 '24Sale0.9115,81314,39045,269Jan 03 04:21 PM
Cale Edgar B.GC & Corporate SecretaryJan 02 '24Sale0.9115,81314,39045,995Jan 03 04:19 PM
King SimonaChief Financial OfficerJul 28 '23Option Exercise0.0031,250035,447Aug 01 04:36 PM
EZGO - EZGO Technologies Ltd - Stock Price Chart
TickerEZGO [NASD]
CompanyEZGO Technologies Ltd
CountryChina
IndustryRecreational Vehicles
Market Cap5.41MEPS (ttm)-0.18
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.34EPS next 5Y-
P/B3.41EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own6.98%Inst Own1.40%
Insider Trans0.00%Inst Trans-
Short Float0.29%Earnings-
Analyst Recom-Target Price-
Avg Volume588.10K52W Range1.52 - 110.80
EZGO Technologies Ltd. operates as a holding company, which engages in selling e-bicycle and battery cells. It operates through the following segments: Battery Cells and Packs, E-Bicycle Sales, Electric Control System and Intelligent Robots Sales. The Battery Cells and Packs Sales segment involves in selling battery packs. The E-Bicycle Sales segment includes selling e-bicycles offline to regional distributors and wholesalers and in online e-commerce platforms to individual customers. The Electronic Control System and Intelligent Robots Sales segment sells customized electronic control system and intelligent robot. The company was founded on January 24, 2019 and is headquartered in Changzhou, China.
OCFT - Oneconnect Financial Technology Co Ltd ADR - Stock Price Chart
TickerOCFT [NYSE]
CompanyOneconnect Financial Technology Co Ltd ADR
CountryChina
IndustrySoftware - Application
Market Cap73.58MEPS (ttm)-1.37
P/E-EPS this Y101.59%
Forward P/E10.92EPS next Y737.72%
PEG-EPS past 5Y21.99%
P/S0.14EPS next 5Y9.19%
P/B0.19EPS Q/Q57.21%
Dividend-Sales Q/Q-26.74%
Insider Own1.10%Inst Own4.47%
Insider Trans0.00%Inst Trans-5.10%
Short Float0.11%EarningsMar 18/b
Analyst Recom1.00Target Price6.98
Avg Volume20.82K52W Range1.75 - 6.00
OneConnect Financial Technology Co. Ltd. engages in providing cloud-native technology solutions to financial institutions in China. Its solutions provide technology applications and technology-enabled business services to financial institutions. It operates through the Technology Solution and Virtual Bank Business segments. The Technology Solution segment includes implementation revenue and transaction-based and support services revenue. The Virtual Bank Business segment represents interest income from the lending business of its virtual bank and fees and commission from the firm's banking operations. The company was founded in December 2015 and is headquartered in Shenzhen, China.
DECA - Denali Capital Acquisition Corp - Stock Price Chart
TickerDECA [NASD]
CompanyDenali Capital Acquisition Corp
CountryUSA
IndustryShell Companies
Market Cap65.41MEPS (ttm)0.06
P/E145.34EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.55EPS Q/Q188.47%
Dividend-Sales Q/Q-
Insider Own39.77%Inst Own40.18%
Insider Trans0.00%Inst Trans84.66%
Short Float0.16%Earnings-
Analyst Recom-Target Price-
Avg Volume40.77K52W Range4.05 - 14.10
Denali Capital Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on January 5, 2022 and is headquartered in New York, NY.
191011121314151617181920